Masimo (MASI) -
Event summary combining transcript, slides, and related documents.
Latest events from Masimo
- Merger with Danaher and executive compensation proposals approved by shareholders.MASI
EGM 202615 May 2026 - Shareholders to vote on $180 per share Danaher merger, with board support and litigation addressed.MASIProxy filing23 Apr 2026
- Shareholders to vote on $180/share all-cash merger with Danaher and related executive compensation.MASIProxy filing1 Apr 2026
- Stockholders to vote on $180/share Danaher acquisition, with board unanimous support and premium offered.MASIProxy Filing18 Mar 2026
- $1B credit facility signed in Dec 2025 with leverage and coverage covenants, maturing 2030.MASIQ4 202527 Feb 2026
- Masimo to be acquired by Danaher for $180 per share, pending shareholder approval.MASIProxy Filing17 Feb 2026
- Board approves $180/share Danaher acquisition; shareholder vote and regulatory review pending.MASIProxy Filing17 Feb 2026
- Shareholders will vote on a $180/share all-cash merger, with closing expected in late 2026.MASIProxy Filing17 Feb 2026
- Q2 revenue up 9% to $496.3M, driven by healthcare growth; non-GAAP EPS $0.86, guidance raised.MASIQ2 20242 Feb 2026
- Stabilized growth, innovation, and a potential JV or spin-off set the stage for margin expansion.MASIGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026